logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Advanced Accelerator Applications USA, Inc drugs

    FiltersReset Filters
    4 results

    • locametz

      (kit for the preparation of gallium Ga 68 gozetotide)
      Advanced Accelerator Applications USA, Inc
      Usage: LOCAMETZ, after radiolabeling with gallium-68, is used for PET imaging of PSMA-positive lesions in men with prostate cancer, aiding in the detection of metastasis, recurrence based on elevated PSA levels, and selection of patients for PSMA-directed therapy.

    • lutathera

      (Lutetium Lu 177 dotatate)
      Advanced Accelerator Applications USA, Inc
      Usage: LUTATHERA is indicated for treating adult and pediatric patients aged 12 and older with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), encompassing foregut, midgut, and hindgut neuroendocrine tumors.

    • netspot

      (68Ga-DOTATATE)
      Advanced Accelerator Applications USA, Inc
      Usage: NETSPOT, after radiolabeling with gallium-68, is indicated for positron emission tomography (PET) to localize somatostatin receptor positive neuroendocrine tumors (NETs) in adult and pediatric patients.

    • pluvicto

      (lutetium Lu 177 vipivotide tetraxetan)
      Advanced Accelerator Applications USA, Inc
      Usage: PLUVICTO is indicated for adult patients with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) who have previously received androgen receptor pathway inhibition and taxane-based chemotherapy.